A higher concentration of the topical retinoid adapalene 0.1% (Differin generic, Gal-derma) is now approved for patients with acne. The new formulation of 0.3% is efficacious enough to treat moderate to moderately severe acne and provides a favorable side-effect profile.
In a randomized, double-blind, parallel-group study, the higher dose resulted in better success rates and demonstrated a fast onset of action.
This prescription medication is odorless and free of oil and alcohol. The gel normalizes the improper accumulation of skin cells that plug the pores and keeps them clear.